MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2017 International Congress

    Anatomical predictors of survival in PSP: thalamic collapse towards the end of life

    W. Bevan-Jones, S. Jones, B. Ghosh, T. Rittman, I. Coyle-Gilchrist, J. Rowe (Cambridge, United Kingdom)

    Objective: To correlate anatomical changes with time to death in PSP. Background: Many advances have been made in progressive supranuclear palsy (PSP) since it was first described…
  • 2017 International Congress

    Long-term Parkinson’s disease progression in PIGD and TD subtypes in the PPMI cohort

    D. Aleksovski, D. Miljkovic, A. Antonini (Ljubljana, Slovenia)

    Objective: Analyze the disease progression and time of therapy initiation for tremor dominant (TD) and postural instability gait disorder (PIGD) subtypes in the PPMI cohort.…
  • 2017 International Congress

    Clinicopathological analysis of corticobasal syndrome: a retrospective study

    R. Lamb, J. Rohrer, R. Weil, H. Ling, A. Lees, H. Morris (London, United Kingdom)

    Objective: Predicting underlying pathology in CBS. Background: Corticobasal syndrome (CBS) is pathologically heterogeneous.  CBS is one of the clinical phenotypes of corticobasal degeneration (CBD) but may…
  • 2017 International Congress

    Secondary Vascular Parkinsonism in Uzbekistan: Hormonal Pathogenetic Effects and Vascular-Immunological Basics.

    D. Akramova (Tashkent, Uzbekistan)

    Objective: We aimed to analyze the PD related hormonal factors and VP hormonal endothelial factors. Background: As we know the Vascular Parkinsonism (VP) and Symptomatic…
  • 2017 International Congress

    Cognitive profiling in patients with Parkinson’s disease, multiple system atrophy and progressive supranuclear palsy: a 15-month longitudinal study

    E. Fiorenzato, L. Weis, A. Antonini, R. Biundo (Venice-Lido, Italy)

    Objective: To characterize the progression of cognitive decline and compare the neuropsychological 15-month profile across PSP, MSA and PD. Background: Cognitive impairments are frequently reported in…
  • 2017 International Congress

    Causes, Complications and Outcomes of Hospitalization in Patients with Dementia with Lewy Bodies

    C. Spears, A. Besharat, D. Martinez-Ramirez, L. Almeida, M. Armstrong (Gainesville, FL, USA)

    Objective: To identify causes, complications and outcomes of hospitalization in patients with dementia with Lewy bodies (DLB). Background: Hospitalization is a known contributor to morbidity…
  • 2017 International Congress

    Epidemiological profile of parkinsonism in a tertiary neurological clinic in the northeast of Brazil.

    R. Prado, P. Macêdo, A. Santiago, R. Sá, J. Santos, M. Machado (Aracaju, Brazil)

    Objective: To identify the epidemiological profile of patients with parkinsonism in a tertiary movement disorders clinic in the northeast of Brazil.To identify the epidemiological profile…
  • 2017 International Congress

    Clinical Phenotype in Patients with Multiple System Atrophy in the Mexican Population

    S. Isais-Millán, C. Perez-Lohman, K. Salinas Barboza, A. Cervantes Arriaga, M. Rodriguez Violante, L. Mendoza Vega, N. Davila Avila, A. DelaCruz Landero (Mexico City, Mexico)

    Objective: To describe the clinical phenotype of patients with MSA in a center in Mexico City Background: Multiple System Atrophy (MSA) is an adult-onset;progressive,neurodegenerative disease…
  • 2017 International Congress

    Lifetime exposure to estrogen and risk for progressive supranuclear palsy

    H.K. Park, I. Litvan, S. Ilango (Goyang-si, Republic of Korea)

    Objective: To investigate the protective effect of estrogen on progressive supranuclear palsy (PSP).   Background: Animal and human epidemiologic studies of Parkinson’s disease and Alzheimer’s dementia have…
  • 2017 International Congress

    Progressive Supranuclear Palsy : About one case at the Neurology Department – Dakar

    L. Belarabi, K. Toure, M. Ndiaye (Dakar, Senegal)

    Objective: We report an observation of a case received at the consultation in the Neurology Department of National Teaching Hospital Fann. Background: Progressive supranuclear palsy…
  • « Previous Page
  • 1
  • …
  • 1215
  • 1216
  • 1217
  • 1218
  • 1219
  • …
  • 1554
  • Next Page »

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
    • Covid vaccine induced parkinsonism and cognitive dysfunction
    • Welcome to the MDS Abstracts Site
    • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
    • Life expectancy with and without Parkinson’s disease in the general population
    • The hardest symptoms that bother patients with Parkinson's disease
    • Effect of marijuana on Essential Tremor: A case report
    • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
    • Covid vaccine induced parkinsonism and cognitive dysfunction
    • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
    • Patients with Essential Tremor Live Longer than their Relatives
    • Help & Support
    • About Us
    • Cookies & Privacy
    • Wiley Job Network
    • Terms & Conditions
    • Advertisers & Agents
    Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
    Wiley